Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01374737Phase 4Unknown
Phase 4, single-arm trial of dexmedetomidine in Emergence agitation (EA), sponsored by Seoul National University Hospital. Primary endpoint: Emergence Agitation at 30 minutes. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01374737.